The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Staphylococcal Infections

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Staphylococcal Infections

 

High impact information on Staphylococcal Infections

 

Chemical compound and disease context of Staphylococcal Infections

 

Biological context of Staphylococcal Infections

 

Anatomical context of Staphylococcal Infections

 

Gene context of Staphylococcal Infections

 

Analytical, diagnostic and therapeutic context of Staphylococcal Infections

References

  1. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. Smith, T.L., Pearson, M.L., Wilcox, K.R., Cruz, C., Lancaster, M.V., Robinson-Dunn, B., Tenover, F.C., Zervos, M.J., Band, J.D., White, E., Jarvis, W.R. N. Engl. J. Med. (1999) [Pubmed]
  2. Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. Zhang, Q., Mousdicas, N., Yi, Q., Al-Hassani, M., Billings, S.D., Perkins, S.M., Howard, K.M., Ishii, S., Shimizu, T., Travers, J.B. J. Clin. Invest. (2005) [Pubmed]
  3. Structural and functional role of threonine 112 in a superantigen Staphylococcus aureus enterotoxin B. Baker, M.D., Papageorgiou, A.C., Titball, R.W., Miller, J., White, S., Lingard, B., Lee, J.J., Cavanagh, D., Kehoe, M.A., Robinson, J.H., Acharya, K.R. J. Biol. Chem. (2002) [Pubmed]
  4. Clinical images: Progressive calcifications and draining lesions following staphylococcal infection in a patient with limited scleroderma. Pando, J., Nashel, D.J. Arthritis Rheum. (1998) [Pubmed]
  5. Staphylococcal pyomyositis in patients infected by the human immunodeficiency virus. Schwartzman, W.A., Lambertus, M.W., Kennedy, C.A., Goetz, M.B. Am. J. Med. (1991) [Pubmed]
  6. Letter: Erythromycin in staphylococcal infections. Kunin, C.M. JAMA (1975) [Pubmed]
  7. Nasal carriage of staphylococcal infection in Wegener granulomatosis. Lawyer, C., Henkle, J., Bakir, H. Ann. Intern. Med. (1994) [Pubmed]
  8. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Muder, R.R., Brennen, C., Wagener, M.M., Vickers, R.M., Rihs, J.D., Hancock, G.A., Yee, Y.C., Miller, J.M., Yu, V.L. Ann. Intern. Med. (1991) [Pubmed]
  9. Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Saravolatz, L.D., Pohlod, D.J., Arking, L.M. Ann. Intern. Med. (1982) [Pubmed]
  10. Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections. Kane, J.G., Parker, R.H., Jordan, G.W., Hoeprich, P.D. Ann. Intern. Med. (1977) [Pubmed]
  11. Treatment of skin, skin structure, bone, and joint infections with ceftazidime. Gentry, L.O. Am. J. Med. (1985) [Pubmed]
  12. Graft infection and bacteremia with Listeria monocytogenes in a patient receiving hemodialysis. Zeitlin, J., Carvounis, C.P., Murphy, R.G., Tortora, G.T. Arch. Intern. Med. (1982) [Pubmed]
  13. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. Calain, P., Krause, K.H., Vaudaux, P., Auckenthaler, R., Lew, D., Waldvogel, F., Hirschel, B. J. Infect. Dis. (1987) [Pubmed]
  14. Different aminoglycoside-resistant phenotypes in a rabbit Staphylococcus aureus endocarditis infection model. Asseray, N., Caillon, J., Roux, N., Jacqueline, C., Bismuth, R., Kergueris, M.F., Potel, G., Bugnon, D. Antimicrob. Agents Chemother. (2002) [Pubmed]
  15. Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus. Carpenter, T.C., Hackbarth, C.J., Chambers, H.F., Sande, M.A. Antimicrob. Agents Chemother. (1986) [Pubmed]
  16. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. Finkelstein, R., Rabino, G., Mashiah, T., Bar-El, Y., Adler, Z., Kertzman, V., Cohen, O., Milo, S. J. Thorac. Cardiovasc. Surg. (2002) [Pubmed]
  17. The role of Staphylococcus aureus sortase A and sortase B in murine arthritis. Jonsson, I.M., Mazmanian, S.K., Schneewind, O., Bremell, T., Tarkowski, A. Microbes Infect. (2003) [Pubmed]
  18. The tetracyclines. Cunha, B.A., Comer, J.B., Jonas, M. Med. Clin. North Am. (1982) [Pubmed]
  19. Staphylococcal enterotoxin B inhibits the production of interleukin-4 in a human mast-cell line HMC-1. Ackermann, L., Pelkonen, J., Harvima, I.T. Immunology (1998) [Pubmed]
  20. Neutrophil pyruvate kinase deficiency with recurrent staphylococcal infections: first reported case. Burge, P.S., Johnson, W.S., Hayward, A.R. British medical journal. (1976) [Pubmed]
  21. Impairment of STAT activation by IL-12 in a patient with atypical mycobacterial and staphylococcal infections. Gollob, J.A., Veenstra, K.G., Jyonouchi, H., Kelly, A.M., Ferrieri, P., Panka, D.J., Altare, F., Fieschi, C., Casanova, J.L., Frank, D.A., Mier, J.W. J. Immunol. (2000) [Pubmed]
  22. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis. Hackett, S.P., Stevens, D.L. J. Infect. Dis. (1993) [Pubmed]
  23. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Ellingsen, E., Morath, S., Flo, T., Schromm, A., Hartung, T., Thiemermann, C., Espevik, T., Golenbock, D., Foster, D., Solberg, R., Aasen, A., Wang, J. Med. Sci. Monit. (2002) [Pubmed]
  24. Urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid follicles. Shapiro, R.L., Duquette, J.G., Nunes, I., Roses, D.F., Harris, M.N., Wilson, E.L., Rifkin, D.B. Am. J. Pathol. (1997) [Pubmed]
  25. Prior elevation of IL-18 promotes rapid early IFN-gamma production during staphylococcal infection. Culshaw, S., Leung, B.P., Gracie, J.A., Campbell, C.C., Thomson, D., Gemmell, C., Liew, F.Y., McInnes, I.B. Eur. J. Immunol. (2005) [Pubmed]
  26. Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis. Brandt, C.M., Rouse, M.S., Tallan, B.M., Laue, N.W., Wilson, W.R., Steckelberg, J.M. Antimicrob. Agents Chemother. (1995) [Pubmed]
  27. Evaluation of a novel fluorescence polarization immunoassay for teicoplanin. Cox, H., Whitby, M., Nimmo, G., Williams, G. Antimicrob. Agents Chemother. (1993) [Pubmed]
  28. Brucella osteomyelitis of a closed femur fracture. Abrahams, M.A., Tylkowski, C.M. Clin. Orthop. Relat. Res. (1985) [Pubmed]
  29. Fusidic acid in other infections. Golledge, C. Int. J. Antimicrob. Agents (1999) [Pubmed]
  30. Antibiotic usage for initial empirical treatment of infections in hospitalized patients in West Germany. Knothe, H. Infection (1991) [Pubmed]
 
WikiGenes - Universities